Simplify Logo

Full-Time

Associate Director

Human Resources Business Partner

Confirmed live in the last 24 hours

Verve Therapeutics

Verve Therapeutics

201-500 employees

Developing gene editing therapies for heart disease

Hardware
Biotechnology
Healthcare

Senior, Expert

Boston, MA, USA

Category
Human Resources
People & HR
Required Skills
Management
Mergers & Acquisitions (M&A)
Requirements
  • B.S. in Business, Management, Human Resources, or related field with 8+ years of Human Resources experience.
  • Biotech experience strongly preferred.
  • Experience with a high growth organization.
  • Exceptional communicator, influencer, and relationship-builder.
  • Proven track record of handling a variety of employee relations issues with a solid understanding of employment law.
  • Exceptional judgment and integrity when making decisions, always considering the bigger picture.
  • Strong analytical skills and ability to use metrics to drive decisions.
  • Ability to work as part of collaborative HR team.
  • Attention to detail is a must.
Responsibilities
  • Build and cultivate strong partnerships with leaders and managers to offer thought leadership on organizational and people-related strategy ensuring a high-performing and engaged workforce.
  • Contribute to the planning and execution of cultural and diversity, equity, and inclusion initiatives and ensure pull-through into our HR processes.
  • Partner with client groups on organizational design and workforce planning to scale the organization for future growth, applying past experience to anticipate potential organizational challenges.
  • Collaborate with hiring managers and Talent Acquisition to develop job descriptions and support strong talent identification and integration.
  • Lead or collaborate in building or enhancing and driving successful rollout of key HR programs including workforce planning, talent review, performance management, promotion process, compensation planning, and employee engagement. Analyze data and prepare presentations for various audiences.
  • Work closely with both management and employees to improve work relationships, build morale, and increase productivity and retention.
  • Facilitate employee relations in a positive, fair, and proactive manner with exceptional judgement.
  • Support teams in understanding and digesting employee feedback and partner on initiatives to strengthen team culture.
  • Facilitate new-hire check-ins and departing employee exit interviews, synthesize themes, diagnose root causes, and provide recommendations to leadership.
  • Other special projects and duties as assigned.

Verve Therapeutics is developing single-course gene editing medicines to address cardiovascular disease, with a focus on precision genetic editing technologies to lower LDL cholesterol and triglyceride levels. Their lead program, VERVE-101, targets heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease.

Company Stage

IPO

Total Funding

$419.3M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

5%

1 year growth

5%

2 year growth

40%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant financial backing, including a $63 million Series A2 financing and $60 million from Eli Lilly, positions Verve for robust R&D and clinical trial activities.
  • The potential for a 'one-and-done' treatment for cardiovascular diseases could revolutionize the field and offer a high-impact, life-saving solution.
  • Early-stage success and strategic partnerships could lead to lucrative licensing deals and further investment opportunities.

What critics are saying

  • The clinical-stage nature of Verve's therapies means they are still years away from potential market approval, posing a long-term risk.
  • The recent stock price drop following a public offering indicates market volatility and potential investor uncertainty.

What makes Verve Therapeutics unique

  • Verve Therapeutics focuses on gene-editing therapies specifically for cardiovascular diseases, setting it apart from other CRISPR-based companies that target a broader range of conditions.
  • Their 'one-and-done' gene-editing approach aims to provide a single, curative treatment, which is a significant advantage over traditional, ongoing therapies.
  • Partnerships with major pharmaceutical companies like Eli Lilly enhance their credibility and provide substantial financial and research support.